Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 12 of 12

List	Outcome	Time frame	Description
Primary	Change from baseline (before start of zoledronic acid treatment) lumbar bone density	through study completion, 4 years	reported in Z-score
Secondary	Age	Baseline
Secondary	Sex	Baseline
Secondary	Height	Baseline
Secondary	Weight	Baseline
Secondary	Occurrence of bone fractures	Until baseline
Secondary	Long-term administration of vitamin/calcium supplement or not	baseline
Secondary	Administration of drugs or not	baseline
Secondary	Number of fractures after the start of zoledronic acid treatment	through study completion, 4 years
Secondary	Change from baseline phosphocalcic profile evaluation	through study completion, 4 years
Secondary	Frequency of side effects	through study completion, 4 years
Secondary	Change from baseline lumbar bone density in sub-population of children with Rett syndrome after 1 year of zoledronic acid treatment	1 year from baseline

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03301285/registered